AI News

OpenAI Launches GPT-Rosalind: Its First Life Sciences AI Model Built to Accelerate Drug Discovery and Genomics Research

OpenAI has officially entered the specialized science race with GPT-Rosalind, a frontier reasoning model designed to slash the 10-15 year timeline of drug discovery through advanced biochemistry and genomic analysis.

The post OpenAI Launches GPT-Rosalind: Its First Life Sciences AI Model Built to Accelerate Drug Discovery and Genomics Research appeared first on MarkTechPost.

Read More »

Why having “humans in the loop” in an AI war is an illusion

The availability of artificial intelligence for use in warfare is at the center of a legal battle between Anthropic and the Pentagon. This debate has become urgent, with AI playing a bigger role than ever before in the current conflict with Iran. AI is no longer just helping humans analyze intelligence. It is now an…

Read More »

Making AI operational in constrained public sector environments

The AI boom has hit across industries, and public sector organizations are facing pressure to accelerate adoption. At the same time, government institutions face distinct constraints around security, governance, and operations that set them apart from their business counterparts. For this reason, purpose-built small language models (SLMs) offer a promising path to operationalize AI in…

Read More »

Treating enterprise AI as an operating layer

There’s a fault line running through enterprise AI, and it’s not the one getting the most attention. The public conversation still tracks foundation models and benchmarks—GPT versus Gemini, reasoning scores, and marginal capability gains. But in practice, the more durable advantage is structural: who owns the operating layer where intelligence is applied, governed, and improved.…

Read More »